ALT

Altimmune Q4 FY25 Earnings Results

Financial Performance and Liquidity Altimmune reported a net loss of $27.4 million, or $0.27 per share, for the fourth quarter…

Altimmune, inc (ALT) Q2 2021 Earnings Conference Call

Altimmune, inc (NASDAQ: ALT) Q2 2021 Earnings Conference

Altimmune, inc (ALT) Altimmune To Announce First Quarter 2021 Financial Results On May 17, 2021

Altimmune, inc (NASDAQ: ALT) Q1 2021 Earnings Conference

Is Altimmune (ALT) stock a buy right now?

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a…

Altimmune (ALT) reports FY19 results; announces vaccine candidate for COVID-19

Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last…